Brain metastases from a primary extracranial malignancy are a very common problem in cancer patients, with an estimated 170,000 new cases per year in the US. While whole-brain radiation therapy (WBRT) was the mainstay of treatment for patients with multiple brain metastases for many years, concern has grown in recent years over the adverse effects of WBRT on neurocognition and quality of life. Consequently, various approaches are being explored to either mitigate the effect of WBRT (eg, memantine, hippocampal-sparing IMRT) or replace this treatment modality entirely (eg, stereotactic radiosurgery, chemotherapy).
Proton therapy for brain metastases: a question of value / Kirkpatrick, J. P.; Laack, N. N.; Halasz, L. M.; Minniti, G.; Chan, M. D.. - In: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. - ISSN 0360-3016. - 101:4(2018), pp. 830-832. [10.1016/j.ijrobp.2018.05.005]
Proton therapy for brain metastases: a question of value
Minniti G.Penultimo
;
2018
Abstract
Brain metastases from a primary extracranial malignancy are a very common problem in cancer patients, with an estimated 170,000 new cases per year in the US. While whole-brain radiation therapy (WBRT) was the mainstay of treatment for patients with multiple brain metastases for many years, concern has grown in recent years over the adverse effects of WBRT on neurocognition and quality of life. Consequently, various approaches are being explored to either mitigate the effect of WBRT (eg, memantine, hippocampal-sparing IMRT) or replace this treatment modality entirely (eg, stereotactic radiosurgery, chemotherapy).| File | Dimensione | Formato | |
|---|---|---|---|
|
Kirkpatrick_Proton therapy_2018.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
166.5 kB
Formato
Adobe PDF
|
166.5 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
